Register Cart 0

Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back Subscribe

Editorial [Hot topic: The Hypoxia-Inducible Factor (HIF) Pathway as a Target for Prevention and Treatment of Clinical Manifestations (Executive Editor: Thomas Kietzmann)]

Author(s): Thomas Kietzmann

Volume 15 , Issue 33 , 2009

Page: [3837 - 3838] Pages: 2

DOI: 10.2174/138161209789649385

Rights & Permissions Print Export Cite as

Article Metrics

13

Journal Information

For Authors & Reviewers

Explore Articles

Open Access

For Visitors

Related Articles

Current Status and Future of Antifungal Therapy for Systemic Mycoses
Recent Patents on Anti-Infective Drug Discovery

Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets
Current Cancer Drug Targets

Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets

Skin Manifestations in Course of Celiac Disease: Case Report and Review of the Literature
Current Pharmaceutical Design

Development of Anti-Atherosclerosis Therapy Based on the Inflammatory and Proliferative Aspects of the Disease
Current Pharmaceutical Design

Recent Understanding of Leukocytapheresis (LCAP) for the Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Design

Modulation of Intracellular Restriction Factors Contributes to Methamphetamine- Mediated Enhancement of Acquired Immune Deficiency Syndrome Virus Infection of Macrophages
Current HIV Research

Pyrroles and Fused Pyrroles: Synthesis and Therapeutic Activities
Mini-Reviews in Organic Chemistry

Central Regulatory Role of Cytokines in Periodontitis and Targeting Options
Current Medicinal Chemistry

Mouse Models of Multiple Sclerosis: Lost in Translation?
Current Pharmaceutical Design

Prostaglandin D2 Receptors DP and CRTH2 in the Pathogenesis of Asthma
Current Molecular Medicine

Non-aspirin Non-steroidal Anti-inflammatory Drugs for the Primary Chemoprevention of Non-gastrointestinal Cancer: Summary of Evidence
Current Pharmaceutical Design

Effects of Arginine on Photostability and Thermal Stability of IgG1 Monoclonal Antibodies
Current Pharmaceutical Biotechnology

Editorial [Hot Topic: Membrane Rafts and Signaling (Guest Editor: Anil Bamezai)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)

Epitope Identification and Discovery Using Phage Display Libraries: Applications in Vaccine Development and Diagnostics
Current Drug Targets

Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis
Current Drug Targets

Long-Term Multimodal Therapy (Verapamil Associated with Propolis, Blueberry, Vitamin E and Local Diclofenac) on Patients with Peyronie's Disease (Chronic Inflammation of the Tunica Albuginea). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued)

Emerging RNA-based Drugs: siRNAs, microRNAs and Derivates
Central Nervous System Agents in Medicinal Chemistry

Synthesis, Characterization of Ethyl 5-(substituted)-1H-pyrazole- 3-carboxylate Derivative as Potent Anti-inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Diagnosis, Prevention and Treatment of Aspirin-Induced Asthma and Rhinitis
Current Drug Targets - Inflammation & Allergy

© 2022 Bentham Science Publishers | Privacy Policy